CDC20P1

Across TCGA pan-cancer cohorts, CDC20P1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated CDC20P1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher CDC20P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CDC20P1 expression acts as an unfavorable survival marker, although some lineages such as UVM and HNSC show a favorable association.

UVM, LUAD, and OV are the cancer types where CDC20P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.883	0.467	<.001	59	view →
LUAD	OS	Tertile	All	0.734	0.849	<.001	48	view →
OV	DFS	Tertile	II,III,IV	0.489	0.594	.005	38	view →
HNSC	OS	Quartile	II,III,IV	0.806	0.666	.008	36	view →
LIHC	OS	Quartile	All	0.576	0.775	<.001	32	view →
MESO	OS	Median	All	0.359	0.201	.010	23	view →
UCS	OS	Quartile	II,III,IV	0.620	0.270	.015	22	view →
CESC	OS	Tertile	II,III,IV	0.858	0.626	.007	20	view →
LGG	OS	Tertile	All	0.736	0.853	.002	19	view →
KICH	OS	Median	All	0.923	1.000	.010	15	view →
GBM	DFS	Tertile	All	0.434	0.220	.009	9	view →
THCA	OS	Quartile	All	0.905	0.986	.025	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

CDC20P1–UVM (OS)

Open the UVM breakdown →